Rifamycin

NEW YORK — Among 75 patients who began rifampin therapy in conjunction with other medications to treat staphylococcal prosthetic joint infection, 23% were rifampin intolerant, a presenter at the Musculoskeletal Infection Society Annual Open Scientific Meeting said.